Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Ernst

Showing results (21-30 of 172) with videos related to

Pageof 18
Sort By:
JAMA|January 21, 2015
Long-acting β-agonists with vs without inhaled corticosteroids for COPDSamy Suissa, Pierre Ernst
Chest|August 10, 2019
ResponseSamy Suissa, Pierre Ernst
COPD|March 2, 2019
Beta-Blockers in COPD: A Methodological Review of the Observational StudiesSamy Suissa, Pierre Ernst
Annals of Internal Medicine|March 19, 2009
How much did biases in the study of chronic obstructive pulmonary disease medications and mortality affect the outcome?Samy Suissa, Pierre Ernst
The European Respiratory Journal|January 2, 2016
The INPULSIS trials of idiopathic pulmonary fibrosis treatment: explaining further discrepancies on exacerbationsSamy Suissa, Pierre Ernst
The American Journal of Medicine|September 28, 2010
Inhaled corticosteroids and the risks of diabetes onset and progressionSamy Suissa, Abbas Kezouh, Pierre Ernst
Chest|June 26, 2015
Discontinuation of Inhaled Corticosteroids in COPD and the Risk Reduction of PneumoniaSamy Suissa, Janie Coulombe, Pierre Ernst
Pulmonary Pharmacology & Therapeutics|May 23, 2007
TNF-alpha antagonists and the prevention of hospitalisation for chronic obstructive pulmonary diseaseSamy Suissa, Pierre Ernst, Marie Hudson
International Journal of Chronic Obstructive Pulmonary Disease|September 6, 2022
Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and SafetySamy Suissa, Sophie Dell'Aniello, Pierre Ernst
COPD|April 8, 2022
Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical PracticeSamy Suissa, Sophie Dell'Aniello, Pierre Ernst
Pageof 18

Showing results (21-30 of 172) with videos related to

Sort By:
Pageof 18
JAMA|January 21, 2015
Long-acting β-agonists with vs without inhaled corticosteroids for COPDSamy Suissa, Pierre Ernst
Chest|August 10, 2019
ResponseSamy Suissa, Pierre Ernst
COPD|March 2, 2019
Beta-Blockers in COPD: A Methodological Review of the Observational StudiesSamy Suissa, Pierre Ernst
Annals of Internal Medicine|March 19, 2009
How much did biases in the study of chronic obstructive pulmonary disease medications and mortality affect the outcome?Samy Suissa, Pierre Ernst
The European Respiratory Journal|January 2, 2016
The INPULSIS trials of idiopathic pulmonary fibrosis treatment: explaining further discrepancies on exacerbationsSamy Suissa, Pierre Ernst
The American Journal of Medicine|September 28, 2010
Inhaled corticosteroids and the risks of diabetes onset and progressionSamy Suissa, Abbas Kezouh, Pierre Ernst
Chest|June 26, 2015
Discontinuation of Inhaled Corticosteroids in COPD and the Risk Reduction of PneumoniaSamy Suissa, Janie Coulombe, Pierre Ernst
Pulmonary Pharmacology & Therapeutics|May 23, 2007
TNF-alpha antagonists and the prevention of hospitalisation for chronic obstructive pulmonary diseaseSamy Suissa, Pierre Ernst, Marie Hudson
International Journal of Chronic Obstructive Pulmonary Disease|September 6, 2022
Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and SafetySamy Suissa, Sophie Dell'Aniello, Pierre Ernst
COPD|April 8, 2022
Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical PracticeSamy Suissa, Sophie Dell'Aniello, Pierre Ernst
Pageof 18